Vahrmeijer AL - Search Results

1

⁸⁹Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study.

Linders DGJ, Deken MM, van Dam MA, Wasser MNJM, Voormolen EMC, Kroep JR, van Dongen GAMS, Vugts D, Oosterkamp HM, Straver ME, van de Velde CJH, Cohen D, Dibbets-Schneider P, van Velden FHP, Pereira Arias-Bouda LM, Vahrmeijer AL, Liefers GJ, de Geus-Oei LF, Hilling DE. Linders DGJ, et al. Among authors: vahrmeijer al. Cancers (Basel). 2023 Oct 13;15(20):4980. doi: 10.3390/cancers15204980. Cancers (Basel). 2023. PMID: 37894346 Free PMC article.

2

Treatment of colorectal cancer metastases confined to the liver.

Vahrmeijer AL, van Dierendonck JH, van de Velde CJ. Vahrmeijer AL, et al. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1238-42. doi: 10.1016/0959-8049(95)00214-4. Eur J Cancer. 1995. PMID: 7577030 Review.

3

Lack of glutathione conjugation of melphalan in the isolated in situ liver perfusion in humans.

Vahrmeijer AL, Snel CA, Steenvoorden DP, Beijnen JH, Pang KS, Schutrups J, Tirona R, Keizer HJ, van Dierendonck JH, van de Velde CJ, Mulder GJ. Vahrmeijer AL, et al. Cancer Res. 1996 Oct 15;56(20):4709-14. Cancer Res. 1996. PMID: 8840988 Clinical Trial.

4

Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.

Kuppen PJ, Jonges LE, van de Velde CJ, Vahrmeijer AL, Tollenaar RA, Borel Rinkes IH, Eggermont AM. Kuppen PJ, et al. Among authors: vahrmeijer al. Br J Cancer. 1997;75(10):1497-500. doi: 10.1038/bjc.1997.255. Br J Cancer. 1997. PMID: 9166943 Free PMC article.

5

Delivery of anticancer drugs via isolated hepatic perfusion: a promising strategy in the treatment of irresectable liver metastases?

Vahrmeijer AL, Van Der Eb MM, Van Dierendonck JH, Kuppen PJ, Van De Velde CJ. Vahrmeijer AL, et al. Semin Surg Oncol. 1998 Apr-May;14(3):262-8. doi: 10.1002/(sici)1098-2388(199804/05)14:3<262::aid-ssu11>3.0.co;2-w. Semin Surg Oncol. 1998. PMID: 9548610 Review.

6

Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases.

Marinelli A, Vahrmeijer AL, van de Velde CJ. Marinelli A, et al. Among authors: vahrmeijer al. Recent Results Cancer Res. 1998;147:83-94. doi: 10.1007/978-3-642-80460-1_9. Recent Results Cancer Res. 1998. PMID: 9670271 Review.

7

Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase I data from humans.

de Vries MR, Borel Rinkes IH, van de Velde CJ, Wiggers T, Tollenaar RA, Kuppen PJ, Vahrmeijer AL, Eggermont AM. de Vries MR, et al. Among authors: vahrmeijer al. Recent Results Cancer Res. 1998;147:107-19. doi: 10.1007/978-3-642-80460-1_11. Recent Results Cancer Res. 1998. PMID: 9670273 Clinical Trial.

8

Potentiation of the cytostatic effect of melphalan on colorectal cancer hepatic metastases by infusion of buthionine sulfoximine (BSO) in the rat: enhanced tumor glutathione depletion by infusion of BSO in the hepatic artery.

Vahrmeijer AL, van Dierendonck JH, Schutrups J, van de Velde CJ, Mulder GJ. Vahrmeijer AL, et al. Cancer Chemother Pharmacol. 1999;44(2):111-6. doi: 10.1007/s002800050954. Cancer Chemother Pharmacol. 1999. PMID: 10412944

9

Effect of glutathione depletion on inhibition of cell cycle progression and induction of apoptosis by melphalan (L-phenylalanine mustard) in human colorectal cancer cells.

Vahrmeijer AL, van Dierendonck JH, Schutrups J, van de Velde CJ, Mulder GJ. Vahrmeijer AL, et al. Biochem Pharmacol. 1999 Aug 15;58(4):655-64. doi: 10.1016/s0006-2952(99)00130-6. Biochem Pharmacol. 1999. PMID: 10413303

10

Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver.

Vahrmeijer AL, van Dierendonck JH, Keizer HJ, Beijnen JH, Tollenaar RA, Pijl ME, Marinelli A, Kuppen PJ, van Bockel JH, Mulder GJ, van de Velde CJ. Vahrmeijer AL, et al. Br J Cancer. 2000 May;82(9):1539-46. doi: 10.1054/bjoc.2000.1175. Br J Cancer. 2000. PMID: 10789721 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page